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tively expressed and markedly accumulated at the recov-
ery phase of ER stress. pXBP1(U) contained the nuclear 
exclusion signal instead of the transcriptional activation 
domain and shuttled between the nucleus and the cyto-
plasm. Interestingly, pXBP1(U) formed a complex with 
pXBP1(S), and the pXBP1(U)–pXBP1(S) complex was se-
questered from the nucleus. Moreover, the complex was 
rapidly degraded by proteasomes because of the degra-
dation motif contained in pXBP1(U). Thus, pXBP1(U) is a 
negative feedback regulator of pXBP1(S), which shuts off 
the transcription of target genes during the recovery 
phase of ER stress.
U
pon the accumulation of unfolded proteins in the 
mammalian endoplasmic reticulum (ER), X-box 
binding protein 1 (XBP1) premessenger RNA 
(premRNA) is converted to mature mRNA by unconven-
tional splicing that is mediated by the endonuclease 
  inositol-requiring enzyme 1. The transcription factor pro-
tein (p) XBP1 spliced (S), which is translated from mature 
XBP1 mRNA, contains the nuclear localization signal 
and the transcriptional activation domain and activates 
the transcription of target genes, including those encod-
ing ER chaperones in the nucleus. We show that pXBP1 
unspliced (U) encoded in XBP1 pre-mRNA was constitu-
Introduction
The folding of nascent proteins is an extremely error-prone 
process, and cells must deal with malfolded proteins, which 
tend to form aggregates, by using molecular chaperones and 
protein degradation machinery. The membrane of the ER in 
mammalian cells contains three sensors (PKR-like ER-resistant 
kinase [PERK], activating transcription factor 6 [ATF6], and 
inositol requiring enzyme 1 [IRE1]) that can monitor the accu-
mulation of unfolded proteins in the ER (ER stress) and acti-
vate elaborate defense mechanisms known collectively as the 
ER stress   response to alleviate the burden of unfolded proteins 
(Kaufman, 1999; Mori, 2000; Urano et al., 2000; Patil and Wal-
ter, 2001). The fi  rst sensor molecule, PERK, is a transmem-
brane kinase that is activated in response to ER stress (Harding 
et al., 1999) and phosphorylates the α subunit of eukaryotic 
translational   initiation factor 2, leading to translational attenua-
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tion to avoid further accumulation of unfolded proteins in the 
ER (Harding et al., 2000). The second sensor, ATF6, a trans-
membrane transcription factor, is transported to the Golgi ap-
paratus upon ER stress and is sequentially cleaved by site-1 and -2 
proteases (Yoshida et al., 1998; Haze et al., 1999, 2001; Ye 
et al., 2000). The liberated cytoplasmic fragment of ATF6, con-
taining a basic leucine zipper motif (pATF6α(N)), translocates 
into the nucleus, binds to the cis-acting ER stress response ele-
ment (ERSE), and activates transcription of ER chaperones 
such as BiP, GRP94, and calreticulin (Yoshida et al., 1998, 
2000, 2001b).
The third sensor, IRE1, is a transmembrane RNase 
  (Tirasophon et al., 1998; Wang et al., 1998; Niwa et al., 1999; 
Iwawaki et al., 2001) involved in the splicing of XBP1 pre-
mRNA   (Yoshida et al., 2001a; Calfon et al., 2002). XBP1 is a 
basic leucine zipper–type transcription factor containing a 
DNA-binding domain and a transcriptional activation domain, 
each encoded by a separate open reading frame on the pre-
mRNA. Upon ER stress, XBP1 pre-mRNA is cleaved by the 
activated IRE1 and ligated by an unidentifi  ed RNA ligase to 
form mature (spliced) XBP1 mRNA, which encodes pXBP1(S) 
  (Yoshida et al., 2001a; Calfon et al., 2002). pXBP1(S) binds to JCB • VOLUME 172 • NUMBER 4 • 2006  566
ERSE to   induce transcription of ER chaperones, and to an-
other cis-acting element, unfolded   protein response element, 
to induce transcription of other genes (probably genes involved 
in ER-associated protein degradation [ERAD]; Yoshida et al., 
2003). The IRE1 signaling pathway is well conserved from 
yeast to mammals. In the budding yeast Saccharomyces cere-
visiae, Ire1p converts HAC1 pre-mRNA to mature mRNA, 
which allows translation of the active transcription factor 
Hac1p to   induce transcription of ER chaperones and ERAD 
components (Cox et al., 1993; Mori et al., 1993, 1996; Cox 
and Walter, 1996).
The splicing of HAC1 and XBP1 pre-mRNAs by IRE1 is 
quite unconventional (Patil and Walter, 2001; Yoshida et al., 
2001a; Calfon et al., 2002). The conventional splicing involves 
an elaborate complex of proteins and RNAs, called the spli-
ceosome, and occurs exclusively in the nucleus, whereas the 
splicing reaction of HAC1 and XBP1 pre-mRNA simply re-
quires IRE1 and RNA ligase, which is completely independent 
of the spliceosome, and takes place in the cytoplasm (Rueg-
segger et al., 2001). Because the removal of an intron from the 
HAC1 and XBP1 pre-mRNAs causes a switching of the read-
ing frame in the COOH-terminal portion of the respective pro-
teins, such splicing could be called “frame switch splicing” 
(Yoshida et al., 2003) or “cytoplasmic splicing” (Ruegsegger 
et al., 2001).
One of the unresolved issues regarding XBP1 is whether 
XBP1 pre-mRNA encodes a functional protein. In yeast, HAC1 
pre-mRNA has a long (252 nt) intron that inhibits translation 
(Chapman and Walter, 1997; Kawahara et al., 1997; Ruegsegger 
et al., 2001). In contrast, unspliced (U) XBP1 pre-mRNA contains 
a much shorter (26 nt) intron and is actively translated to produce 
a protein (pXBP1(U)), although pXBP1(U) is rapidly degraded 
by the proteasome and not detected by immunoblotting (Yoshida 
et al., 2001a; Calfon et al., 2002). It remained possible, however, 
that pXBP1(U) expression was enhanced in certain situations and 
played an important physiological role. Lee et al. (2003) reported 
that pXBP1(U) mutants whose lysine residues were replaced with 
arginine residues were resistant to degradation by proteasomes 
and that overexpression of the mutants repressed transcriptional 
induction by pXBP1(S), suggesting that pXBP1(U) could modu-
late function of pXBP1(S) if its expression was induced.
We examined this problem and revealed an elaborate reg-
ulatory mechanism of mammalian ER stress response taking 
advantage of the dynamic interplay between pXBP1(U) and 
pXBP1(S) that appears critical for swiftly adapting to physio-
logical changes in the ER.
Figure 1.  pXBP1(U) expression is induced during the recovery phase 
of ER stress. (A and B) Accumulation of pXBP1(U) and pXBP1(S) upon 
ER stress. HeLa cells were treated with 2 μg/ml tunicamycin (Tm) or 
300 nM thapsigargin (Tg) for the indicated period, and cell lysates 
were subjected to immunoblotting with anti–XBP1-A (A) and anti-
GAPDH antisera (B). In vitro–translated pXBP1(U) and pXBP1(S) were 
included for comparison. (C and D) Accumulation of XBP1 mRNA 
upon ER stress. Total RNA from cells treated as described in A was 
subjected to Northern blotting with XBP1 (C) and GAPDH (D) cDNA 
probes. (E) Splicing of XBP1 pre-mRNA during ER stress. RT-PCR was 
performed using total RNA extracted from cells treated as described 
in A as a template and the PCR primers shown in Fig. 2 A to discrimi-
nate spliced mature XBP1 mRNA from unspliced pre-mRNA. The am-
pliﬁ  ed cDNA was digested with PstI, which speciﬁ  cally cleaves cDNA 
of XBP1 pre-mRNA, and separated on polyacrylamide gel. (F and G) 
Quantiﬁ   ed data for A–D. pXBP1(U) (closed box), pXBP1(S) (open 
box), and XBP1 mRNA (closed triangle) are shown. (H and I) Accu-
mulation of pXBP1(U) in the recovery phase. HeLa cells treated with 
1 mM DTT for 30 min were washed with PBS as indicated, and 
  lysates were prepared and analyzed by immunoblotting with anti-
XBP1-A (H) antiserum that detects both pXBP1(U) and pXBP1(S) and 
anti-GAPDH (I) antiserum. *, nonspeciﬁ  c bands. (J and K) Accumula-
tion of XBP1 mRNA during the recovery phase. Total RNA isolated 
from cells treated as in H was subjected to Northern blotting with 
XBP1 (J) and GAPDH (K) cDNA probes. (L) Splicing of XBP1 pre-
mRNA in the recovery phase. RT-PCR was performed with total RNA 
as in E. (M and N) Quantiﬁ  ed data for H–K. pXBP1(U) (closed box), 
pXBP1(S) (open box), and XBP1 mRNA (closed triangle) are shown.FUNCTION OF PXBP1(U) ENCODED IN XBP1 PRE-MRNA • YOSHIDA ET AL. 567
Results
Expression of pXBP1(U) is induced during 
the recovery phase of ER stress
It had been postulated that XBP1 pre-mRNA is not translated 
into a functional protein because pXBP1(U) encoded in the pre-
mRNA is rapidly degraded by the proteasome and because en-
dogenous pXBP1(U) cannot be detected by immunoblotting 
(Yoshida et al., 2001a; Calfon et al., 2002). By improving the 
protein extraction protocol, it became possible to detect 
pXBP1(U) protein accumulated in the cells even without prior 
proteasome inhibitor treatment. In cells not treated with ER 
stress inducers, a very small amount of 29-kD pXBP1(U) was 
detected (Fig. 1 A, lanes 1 and 6). Northern blot analysis  revealed 
a certain amount of XBP1 mRNA in these cells (Fig. 1 C, 
lanes 1 and 6). When RT-PCR analysis was performed to 
  differentiate spliced XBP1 mRNA from unspliced pre-mRNA, 
using a pair of primers designed to encompass the intron con-
taining a PstI site (Fig. 2 A), only the bands corresponding to 
unspliced XBP1 mRNA cut with PstI (63 and 297 nt) were de-
tected in uninduced cells (Fig. 1 E, lanes 1 and 6). Upon addi-
tion of tunicamycin (an inhibitor of N-linked glycosylation) or 
thapsigargin (an inhibitor of calcium ATPase in the ER), the 
band of spliced mature mRNA (334 nt) was markedly induced 
(Fig. 1 E, lanes 2–4 and 7–9). This induced splicing was shortly 
followed by a marked expression of pXBP1(S) and XBP1 
mRNA, whereas the amount of pXBP1(U) increased gradually 
(Fig. 1, A and C, lanes 2–4 and 7–9, respectively). At the later 
phase of ER stress, the amount of pXBP1(S) gradually 
  decreased, whereas the amount of pXBP1(U) continued to 
  increase (Fig. 1 A, lanes 5 and 10). At this stage, a large amount 
of XBP1 mRNA was still accumulated (Fig. 1 C, lanes 5 and 10), 
Figure 2.  Expression of the XBP1 target gene wanes during the 
late phase of ER stress. (A) Schematic representation of RT-PCR. 
(B–K) Comparison of induction time course of pXBP1(U), pXBP1(S), 
and EDEM mRNA. HeLa (B–F) and HEK293 cells (G–K) were ana-
lyzed as in Fig. 1. (L) Stability of pXBP1(U) during ER stress. HeLa 
cells transfected with pCMV-HA-pXBP1(U) were incubated in the 
presence or absence of 10 μg/ml tunicamycin for 24 h, and then 
treated with 40 μM cycloheximide for the indicated period. 
Whole cell lysates were extracted and subjected to immunoblot-
ting with anti–XBP1-A antiserum.JCB • VOLUME 172 • NUMBER 4 • 2006  568
and the amount of   unspliced XBP1 mRNA was increased 
(Fig. 1 E, lanes 5 and 10; see the bands of 63 nt). These results 
implied that XBP1 transcription is still vigorous at this stage, 
but an appreciable portion of newly transcribed XBP1 pre-
mRNA remains unspliced, possibly because of the gradual inac-
tivation of IRE1, leading to the enhanced synthesis of pXBP1(U). 
This suggested the interesting possibility that pXBP1(U) ex-
pression is induced at the recovery phase of ER stress. To 
  exclude the possibility that induction of pXBP1(U) at the later 
phase is caused by stabilization of pXBP1(U), we examined 
the stability of pXBP1(U) during ER stress. HeLa cells express-
ing pXBP1(U) were treated with cycloheximide to block de 
novo protein synthesis, and degradation of pXBP1(U) was 
monitored by immunoblotting with anti–XBP1-A antiserum. 
Degradation of pXBP1(U) was enhanced in the later phase of 
ER stress (Fig. 2 L).
We also examined pXBP1(U) expression in human em-
bryonic kidney 293 (HEK293) cells and obtained results similar 
to those observed in HeLa cells (Fig. 2, B–K). Interestingly, the 
kinetics and duration of ER degradation–enhancing mannosidase-
like protein (EDEM) mRNA induction, one of XBP1’s targets 
(Yoshida et al., 2003), correlated well with the expression level 
of pXBP1(S) in HeLa and HEK293 cells (Fig. 2, D and I), and 
EDEM mRNA expression actually waned in the later phase 
(Fig. 2, D and I, lanes 6–8 and 14–16), though the peak of 
EDEM mRNA level was delayed as compared with that of 
pXBP1(S) level. It should be noted that the level of pXBP1(S) 
determines the rate of transcription of EDEM mRNA, whereas 
the data observed in the Northern blots refl  ects accumulation 
of EDEM mRNA.
To confi  rm the notion that pXBP1(U) expression is in-
duced at the recovery phase of ER stress, the expression of 
pXBP1(U) was examined in cells recovering from ER stress in-
duced with DTT, which is a potent inducer yet easily washed 
out to accelerate recovery. As expected, DTT markedly induced 
transcription and splicing of XBP1 mRNA and expression of 
pXBP1(S) protein (Fig. 1, H–L, lanes 1–5). In contrast, when 
DTT was washed out after 30 min of treatment, transcription 
and splicing of XBP1 mRNA gradually decreased to the basal 
level, whereas the accumulation of pXBP1(U) increased (Fig. 1, 
H–L, lanes 6–10). This clearly showed that pXBP1(U) expres-
sion is induced during recovery from ER stress, when XBP1 
mRNA splicing is halted, leading to accumulation of pre-
mRNA. This temporal regulation of pXBP1(U) expression 
  suggested that pXBP1(U) may have an important regulatory 
role in mammalian ER stress response, especially during the 
recovery phase.
pXBP1(U) shuttles between the nucleus 
and cytoplasm
We next analyzed subcellular localization of pXBP1(U) using 
immunofl  uorescent microscopy. When HeLa cells were trans-
fected with plasmid expressing HA-tagged pXBP1(U) or 
pXBP1(S), pXBP1(U) was found in the cytoplasm as well as in 
the nucleus (Fig. 3 A, d–f), whereas pXBP1(S) was specifi  cally 
localized to the nucleus, as   expected (Fig. 3 A, a–c). 
Figure 3.  pXBP1(U) resides in both the nucleus and cyto-
plasm.  (A) Subcellular localization of pXBP1(S) and 
pXBP1(U). HeLa cells transiently transfected with pCMV-
HA-pXBP1(S) or pCMV-HA-pXBP1(U) were stained with 
anti-HA antiserum (left), and the nucleus was stained with 
DAPI (middle). (right) Superimposed image. (B) Subcellu-
lar fractionation of pXBP1(S) and pXBP1(U). Cells trans-
fected as in A were separated into the nuclear (N) and 
postnuclear (C) fractions, and subjected to immunoblot-
ting using anti–XBP1-A. The same blot was also probed 
with anti–lamin B (a nuclear marker) and anti-GAPDH 
(a cytoplasmic marker) antisera. (C) Deletion constructs of 
XBP1 used (number represents amino acid residues en-
coded in unspliced XBP1 mRNA, and asterisk indicates 
amino acid residues encoded in spliced mRNA) and a 
summary of results. The splicing site is indicated by a dot-
ted line. A summary of subcellular localization (N, nuclear; 
C, cytosolic) and degradation by the proteasome (Fig. 6; 
+, rapidly degraded; −, relatively stable) is shown on the 
right. Bars, 10 μm.FUNCTION OF PXBP1(U) ENCODED IN XBP1 PRE-MRNA • YOSHIDA ET AL. 569
We   confi   rmed this result by subcellular fractionation and 
im  munoblotting of HeLa cells (Fig. 3 B).
To determine the amino acid sequence responsible for this 
unexpected localization of pXBP1(U), we constructed and ana-
lyzed a set of deletion mutants of pXBP1(U) (Fig. 3 C). The 
COOH-terminal deletion mutant pXBP1(U)-[1–185] was exclu-
sively localized to the nucleus (Fig. 4, d–f), suggesting that 
the anterior ([1–185]) and posterior ([186–261]) regions of 
pXBP1(U) contain the NLS and cytoplasmic localization signal, 
respectively. Analysis of further COOH-terminal deletions re-
vealed that pXBP1(U)-[1–133] and pXBP1(U)-[1–92] contain-
ing the basic domain were localized to the nucleus (Fig. 4, g–l), 
whereas pXBP1(U)-[1–74], which was lacking the basic do-
main, resided in both the cytoplasm and nucleus (Fig. 4, m–o), 
indicating that the basic domain ([75–92]) functions as a NLS.
On the other hand, pXBP1(U)-[1–208] was predomi-
nantly localized to the cytoplasm (Fig. 4, a–c), as opposed to 
pXBP1(U)-[1–185], which was found only in the nucleus. This 
indicates that the [186–208] region contains a strong nuclear 
exclusion signal (NES) that overcomes the function of the NLS. 
Indeed, this small fragment of 22 amino acid residues was 
  exclusively localized to the cytoplasm (Fig. 4, p–r). To further 
examine the function of the NES, this segment was fused to the 
transcription factor pATF6α(N), which contains a basic domain 
and is solely   expressed in the nucleus (Fig. 5 A, a–c; Haze 
et al., 1999). When expressed in HeLa cells, the fusion protein 
[186–208]-pATF6α(N) was localized to the cytoplasm (Fig. 
5  A, d–f), whereas [209–261]-pATF6α(N) resided in the 
  nucleus (Fig. 5 A, g–i).
The 22-residue NES region represents a leucine-rich 
  sequence that is conserved between human and zebrafi  sh 
pXBP1(U), and is similar to a conventional NES (Lx(2,3)-
[LIVFM]-x(2,3)-L-x-[LI]; Fig. 5 B; la Cour et al., 2003). To 
confi  rm that the nuclear export of pXBP1(U) is mediated by the 
conventional nuclear export machinery, HeLa cells transfected 
with plasmid expressing pXBP1(U)-[1–208] were treated with 
leptomycin B (LMB), an inhibitor for the nuclear export recep-
tor CRM1 (Fornerod et al., 1997), and the localization was ana-
lyzed. pXBP1(U)-[1–208] was expressed in the cytoplasm in 
the absence of LMB (Fig. 5 C, a–c), whereas it was clearly con-
centrated in the nucleus in the presence of LMB (Fig. 5 C, d–f). 
This suggested that the nuclear export of pXBP1(U) is mediated 
Figure 4.  Localization of deletion mutants of pXBP1(U). HeLa cells 
transiently transfected with plasmid expressing indicated deletion mu-
tants were analyzed by immunoﬂ  uorescence microscopy as in Fig. 3 A. 
Bars, 10 μm.
Figure 5.  pXBP1(U) contains a conventional NES. (A) NES of pXBP1(U) is 
functional when fused with a heterologous protein. Localization of 
pATF6α(N) fused with the indicated regions of pXBP1(U) was analyzed as 
in Fig. 3 A. (B) Comparison of amino acid sequences between human 
pXBP1(U)-[165–261] and the corresponding region of zebraﬁ  sh pXBP1(U). 
Identical residues are shaded, and conserved hydrophobic residues are 
marked. (C) Nuclear export of pXBP1(U) is inhibited by LMB. HeLa cells 
transiently transfected with pCMV-HA-pXBP1(U)-[1–208] were treated with 
10 nM LMB for 2 h and analyzed by immunoﬂ  uorescence microscopy as 
in A. Bars, 10 μm.JCB • VOLUME 172 • NUMBER 4 • 2006  570
by the conventional nuclear export machinery and that 
pXBP1(U) shuttles between the nucleus and cytoplasm.
Finally, a comparison of pXBP1(U)-[1–208] (localized to 
the cytoplasm; Fig. 4, a–c) with pXBP1(U)-[1–261] (found in 
both the cytoplasm and nucleus; Fig. 3 A, d–f) suggested that 
the [209–261] region partially attenuates the NES activity of the 
[185–208] region, possibly by sterically hindering the NES 
from interacting with NES receptors.
Identiﬁ  cation of the degradation domain 
in pXBP1(U)
Because pXBP1(U) is very unstable and is rapidly degraded by 
the proteasome (Yoshida et al., 2001a; Calfon et al., 2002), we 
analyzed the region involved in rapid degradation. Plas-
mids carrying deletion derivatives of HA-tagged pXBP1(U) 
were transfected into HeLa cells, and degradation of each mu-
tant protein was evaluated by comparing the protein level in the 
presence or absence of the proteasome inhibitor MG132. The 
amount of intact pXBP1(U) was much increased when cells 
were treated with MG132, which is consistent with rapid degra-
dation by the proteasome (compare Fig. 6 A, lanes 1 and 7), the 
level of COOH-terminal deletion mutants lacking the [209–261] 
region was little affected (Fig. 6 A, lanes 2–6 and 8–12). This 
indicated that the [209–261] region is required for rapid degra-
dation by the proteasome. The level of NH2-terminal deletion 
mutants retaining the [209–261] region also increased by 
MG132 (Fig. 6 B, lanes 13–15 and 19–21), whereas that of de-
letion mutants lacking this region was little affected (Fig. 6 B, 
lanes 16–18 and 22–24), confi  rming our previous conclusion.
We also examined the turnover of pXBP1(U) and its dele-
tion mutants. Cells expressing pXBP1(U) or its derivatives were 
treated with cycloheximide, and whole cell lysates were sub-
jected to immunoblotting. pXBP1(U) was rapidly degraded 
(Fig. 6 C), whereas pXBP1(U) mutants lacking the [209–261] 
region were more stable (Figs. 5 E and 6 D). This confi  rmed the 
aforementioned conclusion that the [209–261] region is indis-
pensable for rapid degradation of pXBP1(U).
pXBP1(U) binds to pXBP1(S)
The aforementioned results prompted us to examine whether 
pXBP1(U) can modulate the function of pXBP1(S), possibly as 
a negative regulator, to shut off transcriptional induction by 
Figure 6. Identiﬁ  cation of the region responsible for rapid 
degradation. Cells were transfected with plasmid expressing 
the indicated deletion mutants of HA-tagged pXBP1(U) and 
treated with 10 μM MG132 for 2 h as indicated. Cell lysate 
was analyzed by Western blotting using anti–XBP1-A anti-
serum (A) and anti-HA serum (B). (bottom) Data quantiﬁ  ed by 
an image analyzer. (C–E) Stability of pXBP1(U) and its mu-
tants. Cells expressing pXBP1(U) (left), pXBP1(U)-[1–208] 
(middle), and pXBP1(U)-[1–185] (right) were treated with 
40 μM cycloheximide for the indicated period, and cell 
  lysates were subjected to immunoblotting with anti–XBP1-A 
antiserum. (bottom) Averages from two independent experi-
ments are presented with standard deviation values.FUNCTION OF PXBP1(U) ENCODED IN XBP1 PRE-MRNA • YOSHIDA ET AL. 571
pXBP1(S). Thus, we investigated whether pXBP1(U) binds to 
pXBP1(S) when coexpressed in vivo. HeLa cells were tran-
siently transfected with a plasmid expressing Histidine-tagged 
pXBP1(S), together with a plasmid expressing XBP1(U), and 
whole cell lysate was incubated with Ni-NTA resin to bind His-
pXBP1(S). Evidently, pXBP1(U) was specifi  cally copurifi  ed 
with His-pXBP1(S) in this pull-down assay (Fig. 7 A, lanes 5–8), 
suggesting that pXBP1(U) associates with pXBP1(S) under 
these conditions. We then tested whether pXBP1(U) binds to 
pXBP1(S) synthesized in vitro. His-pXBP1(S) and pXBP1(U) 
(or a deletion mutant pXBP1(U)-[1–208]) were simultaneously 
translated in the same reaction using rabbit reticulocyte lysates, 
and the resulting products were treated with Ni-NTA resin. 
pXBP1(U), as well as pXBP1(U)-[1–208], was specifi  cally co-
purifi  ed with His-pXBP1(S) (Fig. 7 B, lanes 7–12). These re-
sults suggested that pXBP1(U) synthesized in vitro can directly 
bind to pXBP1(S).
pXBP1(U) sequesters pXBP1(S) 
from the nucleus and enhances degradation
We next examined the physiological implication of the interac-
tion between pXBP1(S) and pXBP1(U). Based on the results 
presented in Fig. 7, most pXBP1(S) was expected to interact 
with pXBP1(U) in the presence of excess pXBP1(U). To com-
pare the stability of the pXBP1(S)–pXBP1(U) complex with 
pXBP1(S), HeLa cells were transfected with a plasmid express-
ing pXBP1(S), together with a ninefold excess of a plasmid ex-
pressing pXBP1(U) or vector alone, and the accumulation of 
pXBP1(S) was examined by immunoblotting using anti–XBP1-C 
that specifi  cally recognizes pXBP1(S) (Yoshida et al., 2001a). 
Under these conditions, pXBP1(U) was   expressed in great ex-
cess over pXBP1(S) (Fig. 8 A, lane 2), and the level of pXBP1(S) 
was markedly reduced by overexpression of pXBP1(U) as com-
pared with cells cotransfected with vector alone (Fig. 8 B, lanes 
1 and 2). This effect of pXBP1(U) overexpression was greatly 
compromised by the proteasome inhibitor MG132 (Fig. 8 B, 
lanes 4 and 5), suggesting that pXBP1(S)–pXBP1(U) is more 
susceptible to degradation by the proteasome than pXBP1(S). 
Interestingly, overexpression of pXBP1(U)-[1–185] lacking the 
“degradation domain” identifi  ed in Fig. 6 had little effect on 
the stability of pXBP1(S) (Fig. 8 B, lanes 3 and 6), though 
pXBP1(U)-[1–185] was expressed at a level similar to pXBP1(U) 
(Fig. 8 A, lane 3). This is also consistent with the notion that the 
degradation domain of pXBP1(U) is indispensable for rapid 
degradation of the pXBP1(S)–pXBP1(U) complex.
We confi  rmed these notions by examining the turnover 
of pXBP1(S) in the presence or absence of abundant pXBP1(U). 
Cells transfected as in Fig. 8 B were treated with cyclohexi-
mide, and whole cell lysates were subjected to immunoblot-
ting. Coexpression of pXBP1(U) signifi  cantly  accelerated 
pXBP1(S) degradation (Fig. 8 C, left and middle), whereas 
that of pXBP1(U)-[1–185] hardly effected pXBP1(S) stability 
(Fig. 8, right).
We also analyzed subcellular localization of the 
pXBP1(S)–pXBP1(U) complex using HeLa cells cotransfected 
with plasmid expressing pXBP1(S) and a ninefold excess of 
plasmid expressing pXBP1(U), which resulted in speckled 
staining in the cytoplasm and reduced staining in the nucleus 
(Fig. 9 A, d–f). In contrast, pXBP1(S) was located solely in 
the nucleus (Fig. 9 A, a–c). Interestingly, coexpression of 
pXBP1(U)-[1–185] lacking the NES did not affect pXBP1(S) 
localization (Fig. 9 A, g–i). This suggested that pXBP1(S)–
pXBP1(U) was exported from the nucleus to cytoplasm and that 
the NES contained in pXBP1(U) is essential for this export,
Figure 7. Speciﬁ  c binding of pXBP1(U) to pXBP1(S). (A) Coexpression of 
the two proteins in vivo. Cell lysates were prepared from HeLa cells trans-
fected with pCMV-His-pXBP1(S) and/or pCMV-pXBP1(U), and the lysates 
were subjected to pull-down assays using Ni-NTA agarose. Input and 
bound materials were analyzed by immunoblotting with anti–XBP1-A anti-
body. (B) Mixing of two proteins synthesized in vitro. Indicated proteins 
were translated in vitro using rabbit reticulocyte lysates and analyzed 
  essentially as in A. *, nonspeciﬁ  c banding.
Figure 8.  Level and stability of the pXBP1(S)–pXBP1(U) complex. (A and B) 
HeLa cells were transiently cotransfected with pCMV-pXBP1(S) and a nine-
fold excess of pCMV-pXBP1(U) or pCMV-pXBP1(U)-[1–185] and were 
treated with 10 μM of the proteasome inhibitor MG132 for 2 h before 
harvest, as indicated. Whole cell lysate was subjected to Western blotting 
using anti–XBP1-A antiserum (A) or anti–XBP1-C antiserum (B). (C) Cells 
transfected as in B were treated with 40 μM cycloheximide for the indi-
cated period, and cell lysates were subjected to immunoblotting with anti–
XBP1-A antiserum. *, nonspeciﬁ  c banding.JCB • VOLUME 172 • NUMBER 4 • 2006  572
although the signifi   cance of the speckled staining observed 
 remained  unknown.
We confi   rmed this notion by subcellular fractionation 
  experiments. Cells transfected as in Fig. 9 A were separated 
into the nuclear and postnuclear (cytoplasmic) fractions and 
  subjected to immunoblotting with anti–XBP1-A antiserum. 
pXBP1(S) was localized in the nuclear fraction when it was 
  expressed (Fig. 9 B, lanes 5 and 6). When pXBP1(U) was coex-
pressed, most of pXBP1(S) was actually found in the postnu-
clear fraction (Fig. 9 B, lanes 7 and 8), whereas coexpression of 
pXBP1(U)-[1–185] did not affect pXBP1(S) localization 
(Fig. 9 B, lanes 1 and 2).
Finally, we examined the effect of pXBP1(U) coexpres-
sion on expression of pXBP1(S) target genes. Total RNA was 
extracted from cells transfected as in Fig. 9 A, and subjected to 
Northern blotting. Accumulation of BiP mRNA was enhanced 
in cells expressing pXBP1(S) (Fig. 9 C, lanes 1 and 2). In con-
trast, this induction was abolished by coexpression of pXBP1(U) 
(Fig. 9 C, lane 3), whereas it was not affected by coexpression 
of pXBP1(U)-[1–185] (Fig. 9 C, lane 4). These results strongly 
suggested that pXBP1(U) functions as a negative feedback 
  regulator of pXBP1(S).
Discussion
We revealed that pXBP1(U) translated from the unspliced pre-
mRNA represents a functional protein with an important role in 
mammalian ER stress response. One interesting characteristic 
of pXBP1(U) is that it contains three distinct subcellular local-
ization determinants, which are the NLS, NES, and NES attenu-
ator (Fig. 3 B). The functional balance among these signals 
appears to determine the subcellular location of XBP1 proteins 
under diverse physiological and environmental   conditions. 
pXBP1(U), which contains all of these signals, can shuttle back 
and forth between the nucleus and the cytoplasm (Fig. 3 A). 
pXBP1(S) contains only the NLS and is located exclusively in 
the nucleus (Fig. 3 A). Interestingly, the pXBP1(S)–pXBP1(U) 
complex was localized to the cytoplasm (Fig. 9). Conforma-
tional changes evoked by the formation of this complex might 
cancel the NES attenuator activity. Although the molecular 
mechanism behind the attenuation remains unknown, it is pos-
sible that the attenuator sterically prevents NES receptors such 
as CRM1 from approaching the NES. The XBP1(U)-[186–261] 
region contains two highly conserved domains, a conventional 
NES motif ([186–208]), and a SWKPLMN motif at the very 
end (Fig. 5 B), and the latter might be important for the attenua-
tion or for degradation by the proteasome.
pXBP1(U) also contains a “degradation domain” in the 
[209–261] region that makes it more susceptible to degradation 
by the proteasome. Because pXBP1-[1–208], which lacks the 
degradation domain and is exclusively localized to the cyto-
plasm, is clearly more stable than pXBP1(U) (Fig. 6 A), the 
  cytoplasmic localization by itself is not suffi   cient for rapid 
  degradation. Although pXBP1(S) does not contain the degrada-
tion domain, it becomes less stable when it forms a complex 
with pXBP1(U), possibly because the degradation domain of 
pXBP1(U) is presented to the degradation machinery.
Taking our fi  ndings into account, as well as the fact that 
pXBP1(U) expression is signifi  cantly induced during recovery 
from ER stress, we propose a working model of pXBP1(U) 
function in mammalian ER stress response (Fig. 10 A). In the 
absence of ER stress, pXBP1(U) protein is translated from 
XBP1 pre-mRNA and shuttles between the cytoplasm and the 
nucleus to monitor the level of pXBP1(S), and possibly that of 
inopportune expression of pATF6(N) as well because pXBP1(U) 
can form a heterooligomer with pATF6(N) (Newman and 
Figure 9.  Subcellular localization of the pXBP1(S)–pXBP1(U) complex. 
(A) HeLa cells transfected as in Fig. 8 C were stained with anti–XBP1-C 
  antiserum (left) or with DAPI (middle). (B) Cells that were transfected as in 
A were separated into the nuclear (N) and postnuclear fractions (C), and 
subjected to immunoblotting as in Fig. 3 B. (C) Total RNA extracted from 
cells that were transfected as in A was subjected to Northern blotting with 
BiP and GAPDH cDNA probes. (right) Quantiﬁ  ed data. The level of BiP 
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  Keating, 2003). Upon ER stress, activated IRE1 splices XBP1 
pre-mRNA into mature mRNA, from which pXBP1(S) is trans-
lated. pXBP1(S) is then translocated into the nucleus, and acti-
vates transcription of targets such as ER chaperones and ERAD 
components. When enough ER chaperones and ERAD compo-
nents are produced and ER stress has subsided, IRE1 becomes 
inactive, but a certain level of pXBP1(S) remains in the nucleus, 
leading to further transcription of XBP1 pre-mRNA and pro-
duction of pXBP1(U). pXBP1(U) shuttles between the cyto-
plasm and the nucleus and forms a complex with pXBP1(S) left 
over in the nucleus. The pXBP1(S)–pXBP1(U) complex that 
may expose NES is effi  ciently exported from the nucleus to the 
cytoplasm and degraded by the proteasome by virtue of the deg-
radation motif in pXBP1(U), resulting in a complete shutoff of 
transcription of the target genes. Thus, it seems very likely that 
pXBP1(U) functions as a negative feed-back regulator specifi  c 
to pXBP1(S) (and possibly to pATF6(N) as well). Such a shut-
off mechanism would clearly be benefi  cial for cell survival be-
cause constitutive activation of the ER stress response would 
be harmful and is known to retard cell growth in yeast (Cox and 
Walter, 1996; Kawahara et al., 1997).
To our knowledge, this study identifi  ed the fi  rst case in 
which a functional protein was translated from pre-mRNA. The 
fi  ndings suggest that cytoplasmic mRNA splicing is a very so-
phisticated mechanism of gene regulation as compared with 
conventional nuclear mRNA splicing, which is catalyzed by the 
spliceosome (Fig. 10 B). In conventional splicing, which occurs 
in the nucleus, it would be diffi  cult to resplice mRNA if it has 
already been exported to the cytoplasm. Thus, it would be nec-
essary to transcribe and splice the primary transcript de novo to 
accommodate possible change in amino acid sequence of prod-
uct protein translated from the mRNA. In contrast, in the case of 
cytoplasmic splicing, pre-mRNA that is transported to the cyto-
plasm and used for translation can be respliced when necessary 
to change the structure of product protein translated from the 
mRNA, in response to extracellular or intracellular signals. 
Thus, cytoplasmic splicing would be a very rapid, versatile, and 
energy-effi  cient mechanism with minimum garbage, as com-
pared with conventional mRNA splicing. The ER stress re-
sponse may require such a sophisticated system to effectively 
exploit the interplay between pXBP1(U) and pXBP1(S) to deal 
with malicious unfolded proteins accumulated in the ER. More-
over, it is conceivable that other systems or cellular processes, 
such as development or antiviral response, adopt similar mech-
anisms in which cytoplasmic splicing plays an essential role. 
Identifi  cation of such systems would greatly increase our under-
standing of cellular response mechanisms to cope with various 
physiological and pathological situations.
Materials and methods
Cell culture
HeLa cells were grown in DME/glucose at 4.5 g/liter supplemented 
with 10% fetal calf serum, 2 mM glutamine and antibiotics, 100 U/ml 
penicillin/100 μg/ml streptomycin. Cells were maintained at 37°C in a 
humidiﬁ  ed 5% CO2/95% air atmosphere.
Transient transfection of cultured cells
Transient transfection was performed by the standard calcium phosphate 
method (Sambrook et al., 1989; Yoshida et al., 2001a). In brief, HeLa cells 
cultured in 60-mm dishes were incubated with precipitates of calcium phos-
phate, including plasmids, for 6 h at 37°C. After washing with PBS to re-
move calcium phosphate precipitates, cells were incubated in fresh medium 
for 24 h and harvested for analysis. For subcellular fractionation, trans-
fected cells were suspended in 100 μl of ice-cold PBS containing protease 
inhibitors and 5% NP-40 and separated into the nuclear and postnuclear 
fractions by centrifugation at 14,000 rpm for 1 min. For turnover analysis, 
transfected cells were treated with 40 μM cycloheximide for the indicated 
period and subjected to immunoblotting. LMB was provided by M. Yoshida 
(Institute of Physical and Chemical Research, Saitama, Japan).
Construction of plasmids
To construct pCMV-HA-pXBP1(U) and pCMV-HA-pXBP1(S), 1,787- and 
1,761-bp fragments, respectively, of XBP1 cDNA encoding pXBP1(U) and 
pXBP1(S) were cloned into an XhoI site of pCMV-HA vector (CLONTECH 
Laboratories, Inc.). Expression plasmids for a series of pXBP1(U) deletion 
mutants fused with HA tag were made by ligating the PCR product of the 
corresponding region with pCMV-HA. pCMV-HA-pATF6α(N) was con-
structed by inserting a cDNA encoding the [1–373] region of human 
ATF6α into BglII–XhoI sites of pCMV-HA vector. For construction of pCMV-
HA-pXBP1-[165–261]-pATF6α(N), cDNA encoding the [165–261] region 
of human pXBP1(U) was cloned into a BglII site of pCMV-HA-pATF6α(N). 
pcDNA-His-pXBP1(S) was made by inserting pXBP1(S) cDNA into an XhoI 
site of pcDNA3.1-His vector (Promega).
Immunoblotting
Cells grown in a 60-mm culture dish were harvested with a rubber police-
man and pelleted by centrifugation. The pellet was suspended in 20 μl of 
ice-cold PBS containing protease inhibitors (100 μM 4-(2-Aminoethyl)benz-
enesulphonyl ﬂ  uoride, 80 μM aprotinin, 1.5 μM E-64, 2 μM leupeptin, 
5 μM bestatin, and 1 μM pepstatin A), mixed with 20 μl of 4× SDS sam-
ple buffer (200 mM Tris-Cl, pH 6.8, 400 mM DTT, 8% SDS, and 40% glyc-
erol), and immediately boiled at 100°C. 10-μl portions of samples were 
subjected to SDS-PAGE using 4–20% gradient gels, transferred onto a 
  Hybond-P ﬁ   lter (GE Healthcare), and incubated with various antisera 
  according to the standard protocol (Sambrook et al., 1989). Anti–XBP1-A 
Figure 10. Models.  (A) The model for pXBP1(U) function in mammalian ER 
stress response. pXBP1(U) and pXBP1(S) are depicted as U and S,  respectively. 
(B) Comparison between conventional and cytoplasmic splicing.JCB • VOLUME 172 • NUMBER 4 • 2006  574
detects both pXBP1(U) and pXBP1(S), whereas anti–XBP1-C detects only 
pXBP1(S) (Yoshida et al., 2001a). An ECL Western blotting detection kit 
(GE Healthcare) and lumino-image analyzer (model LAS-3000; Fuji) were 
used to detect antigens.
Northern blot hybridization analysis
Total RNA extracted with guanidine-phenol was separated by electropho-
resis with 2% agarose gel containing 2.2 M formaldehyde, blotted onto a 
Hybond-N+ ﬁ  lter (GE Healthcare), hybridized with alkaline phosphatase-
conjugated cDNA probes, and detected with a LAS-3000 using the Gene 
Images AlkPhos direct labeling and detection system (GE Healthcare).
RT-PCR
RT-PCR of XBP1 mRNA was performed essentially as described previ-
ously (Yoshida et al., 2001a). In brief, 10 μg of total RNA was reverse-
transcribed with M-MLV reverse transcriptase (Invitrogen) and ampliﬁ  ed with   
Ex Taq polymerase (TaKaRa) using a pair of primers that correspond to nt 
493–512 (C G  C  G  G  A  T  C  C  G  A  A  T  G  A  A  G  T  G  A  G  G  C  C  A  G  T  G  G  ) and 834–853 
(G  G  G  G  C  T  T  G  G  T  A  T  A  T  A  T  G  T  G  G  ) of XBP1 mRNA, respectively (Fig. 2 A). 
Ampliﬁ  ed fragments covering a 26-nt intron (nt 531–556) and ﬂ  anking 
exon fragments were digested with PstI (a unique PstI site existed at nt 556) 
and separated on 4–20% polyacrylamide gels. cDNA was visualized by 
staining with SYBR Gold (Invitrogen) and detected by a Fluor-image ana-
lyzer (model FLA-3000; Fuji).
Immunocytochemistry
HeLa cells grown on coverslips were transiently transfected with appropri-
ate expression plasmids by the calcium phosphate method. Cells were 
ﬁ  xed with 2% paraformaldehyde for 10 min, permeabilized with 0.2% 
  Triton X-100 for 10 min, and stained with the appropriate antisera. Cover-
slips were mounted with 90% glycerol/10% PBS containing 100 ng/ml 
DAPI. Images were acquired using a microscope (model TE2000; Nikon) and 
a digital charge-coupled device camera (ORCA-ER; Hamamatsu Photonics).
Pull-down assay
For in vivo pull-down assays, HeLa cells were cotransfected with expression 
plasmids for His-pXBP1(S) and pXBP1(U), harvested by rubber policeman, 
lysed in binding buffer (20 mM Hepes, pH 7.9, 100 mM KCl, 10% glyc-
erol, 1 mM MgCl2, 1 mM mercaptoethanol, 0.1% Tween-20, and 20 mM 
imidazole), and centrifuged. Supernatants were mixed with Ni-NTA aga-
rose in binding buffer containing protease inhibitors for 1 h at 4°C, washed 
with binding buffer three times, and then suspended in 1× SDS sample buf-
fer. Samples were boiled at 100°C and subjected to 4–20% SDS-PAGE. 
pXBP1(U) coprecipitated with His-pXBP1(S) was detected by immunoblotting 
with anti–XBP1-A antiserum. For in vitro pull-down assays, both His-
pXBP1(S) protein and pXBP1(U) protein were cotranslated using TNT Quick 
Coupled Transcription/Translation systems (Promega), incubated with 
Ni-NTA agarose for 1 h at 4°C, and processed like the HeLa cells.
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